OmniAb reports preliminary year-end cash of ~$88M; attending J.P. Morgan conference

OmniAb, Inc.

Preliminary unaudited cash, cash equivalents and marketable securities as of Dec 31, 2022: approximately $88M.
Estimate is subject to completion of financial closing procedures and audit, may change materially.
Company representatives attending J.P. Morgan Healthcare Conference starting Jan 9, 2023.
Updated corporate presentation posted on OmniAb's website; no further 8-K updates planned for future changes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.